MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...

BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and wound care products, is pleased to announce the approval of its randomized control trial designed to ...

MediWound (NASDAQ:MDWD) stock climbed 4% following news that the company has initiated a Phase 3 study of its wound care product EscharEX in the treatment of venous leg ulcers, or VLU. The company ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use, according to new ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Compression socks help improve blood flow and reduce swelling in the feet and ankles. Here’s everything to know to decide if ...

Introduction Wound debridement is a critical medical procedure used to treat various types of wounds, including burns, <a target=_blank href= ...

Discover the latest research on the management of venous leg ulcers. This Consensus Statement provides concise guidance for healthcare providers in Canada.